510(k) Report

510(k) · Cleared

Cleared

Quantib ND

K213737510(k) SpecialCleared Jan 14, 202246-day reviewClass II21 CFR 892.2050

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Quantib B.V. · LLZ System, Image Processing, Radiological

Cleared on Jan 14, 2022 as substantially equivalent to K182564 (Quantib B.V., 2018) after a 46-day review. Its family tree reaches back 6 generations to 2001. 1 later device descends from it.

Decided
Jan 14, 2022
Review
46 days
Class
Class II
Product code
LLZ
Recalls
None
Predicates
1

Its longest line of descent runs back 6 generations to K011196 (2001). 1 later device descends from it, 1 citing it directly.

  1. Root · 6 generations backK011196 Iquantify, Version 1.0Insightful Corporation · 2001
  2. 5 generations backK050703 QbrainMedis Medical Imaging Systems BV · 2005
  3. 4 generations backK153351 Quantib Brain 1Quantib B.V. · 2016
  4. 3 generations backK163013 Quantib Brain 1.2Quantib B.V. · 2017
  5. 2 generations backK173939 Quantib BrainQuantib B.V. · 2018
  6. 1 generation backK182564 Quantib NDQuantib B.V. · 2018
  7. This deviceK213737 Quantib NDQuantib B.V. · 2022
  8. Descendant · cites it directly · 0 of its ownK251527 Brain WMHQuantib B.V. · 2025

Most influential descendants

Showing 1 of 1 · See all
  • K251527Brain WMHQuantib B.V. · 2025 · cites it directly0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K011196Iquantify, Version 1.0Insightful Corporation2001—
−5K050703QbrainMedis Medical Imaging Systems BV2005—
−4K153351Quantib Brain 1Quantib B.V.2016—
−3K163013Quantib Brain 1.2Quantib B.V.2017—
−2K173939Quantib BrainQuantib B.V.2018—
−1K182564Quantib NDQuantib B.V.2018—
0 (this device)K213737Quantib NDQuantib B.V.2022—
+1K251527Brain WMHQuantib B.V.2025—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
202510
FIG. 1 — Lineage of K213737, 2001–2025Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LLZ? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LLZ device

  1. #1 K230955 syngo Application Softwarescore 21.5 · 11 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K182564Quantib ND
Summary page 4
…ment and processing system (former Picture archiving and communication system) 3 PREDICATE DEVICE Device: Quantib ND 1.5 Manufacturer: Quantib B.V. 510(k) Reg. No: K182564 This predicate has not been subject to a design-related recall. Classification Name: System, image processing, radiology (892.205…
Quantib B.V.2018—

What descends from it? (1)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K251527Brain WMHQuantib B.V.20250

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 21 years and passes through 3 companies; a new generation was cleared every 3.0 years on median.
  • None of the 6 ancestors has a recall.
  • Of its descendants, K251527 (Quantib B.V., 2025) has gone furthest, with 0 descendants of its own.

How does its category compare?

All LLZ devices

LLZ System, Image Processing, Radiological: FDA decisions, review times, recalls and adverse event reports over 20 years. 2022, this device’s year, is highlighted.

FDA decisions per year · LLZ

58in 2025

2007: 762008: 942009: 702010: 512011: 1062012: 822013: 952014: 782015: 642016: 822017: 782018: 1042019: 742020: 812021: 832022: 652023: 872024: 622025: 582026 (partial year): 45
2007high 106 (2011) · low 51 (2010)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LLZ

173in 2025

2007: 36 days median2008: 52 days median2009: 62 days median2010: 98 days median2011: 79 days median2012: 87 days median2013: 84 days median2014: 89 days median2015: 90 days median2016: 90 days median2017: 107 days median2018: 105 days median2019: 107 days median2020: 115 days median2021: 116 days median2022: 137 days median2023: 157 days median2024: 131 days median2025: 173 days median2026 (partial year): 110 days median
2007high 173 (2025) · low 36 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LLZ

11in 2025

2007: 202008: 322009: 212010: 172011: 302012: 122013: 642014: 62015: 162016: 122017: 52018: 72019: 22020: 62021: 32022: 42023: 82024: 62025: 112026 (partial year): 14
2007high 64 (2013) · low 2 (2019)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · LLZ

116in 2025

2007: 1522008: 1542009: 1452010: 1452011: 4542012: 2662013: 1,1302014: 15,6312015: 2112016: 2902017: 1042018: 722019: 882020: 822021: 702022: 282023: 262024: 422025: 116
2007high 15,631 (2014) · low 26 (2023)2025

MAUDE reports naming product code LLZ, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007763620152
2008945232154
2009706221145
2010519817145
20111067930454
2012828712266
20139584641,130
20147889615,631
2015649016211
2016829012290
2017781075104
2018104105772
201974107288
202081115682
202183116370
202265137428
202387157826
202462131642
20255817311116
20264511014—

What is it indicated for?

Quantib ND is a non-invasive medical imaging processing application that is intended for automatic labeling, visualization, and volumetric quantification of segmentable brain structures from a set of magnetic resonance (MR) images. The Quantib ND output consists of segmentations, visualizations and volumetric measurements of brain structures and white matter hyperintensities. Volumetric measurements may be compared to reference centile data. It is intended to provide the trained medical professional with complementary information for the evaluation and assessment of MR brain images and to aid the trained medical professional in quantitative reporting.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K213737: Quantib ND.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K213737

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026